Skip to main content
logo
Metagenomi Therapeutics, Inc. (MGX)
NASDAQ: MGX · Real-Time Price · USD
1.230
+0.010 (0.82%)
At close: Aug 13, 2026, 4:00 PM EDT
1.210
-0.020 (-1.63%)
After-hours: Aug 13, 2026, 7:45 PM EDT

Metagenomi Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-93.46-87.87-78.06-68.26-43.59-21.44
Depreciation & Amortization
5.165.325.414.211.730.39
Stock-Based Compensation
10.5211.8516.26.921.960.38
Other Adjustments
3.813.97.04-7.850.14-1.32
Change in Receivables
0.870.951.19-2.45--
Changes in Accounts Payable
-0.121.05-1.11-0.080.720.7
Changes in Accrued Expenses
1.72-1.64-0.891.634.531.85
Changes in Income Taxes Payable
---3.271.731.54-
Changes in Unearned Revenue
-11.17-21.1-46.8-30.365.6644.23
Changes in Other Operating Activities
-3.46-1.36-8.793.04-2.96-0.52
Operating Cash Flow
-85.49-88.89-109.07-91.4129.7224.26
Operating Cash Flow Growth
----22.54%-

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-0.31-0.57-3.11-9.81-13.98-2.9
Sale of Property, Plant & Equipment
-0.04----
Purchases of Investments
-66.27-66.41-306.42-208.1-214.85-71.41
Proceeds from Sale of Investments
163.46170.47221.38263.64106.63-
Investing Cash Flow
96.88103.53-88.1645.73-122.2-74.32

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Issuance of Common Stock
0.170.284.01---
Net Common Stock Issued (Repurchased)
0.170.284.01---
Issuance of Preferred Stock
---4.3239.599.95
Net Preferred Stock Issued (Repurchased)
---4.3239.599.95
Other Financing Activities
-0.24-0.56--3.28-29.97
Financing Cash Flow
-0.07-0.3684.011.01239.5939.92

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
11.3214.28-113.22-44.66147.12-10.14

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-85.8-89.47-112.19-101.2215.7521.35
Free Cash Flow Growth
-----26.26%-
FCF Margin
-632.67%-354.88%-214.53%-226.17%91.55%8787.65%
Free Cash Flow Per Share
-2.29-2.40-3.40-29.734.636.27
Levered Free Cash Flow
-101.64-106.17-136.63-97.8413.6522.3
Unlevered Free Cash Flow
-108.54-114.25-141.61-118.549.8119.79
SEC Filings: 10-K · 10-Q